Platinum ethylenedicysteine glucosamine (CellPoint)

N/A

Report date: 2024/04/07 16:38:02
NME

Base Information

Drug NamePlatinum ethylenedicysteine glucosamine (CellPoint)
Drug Alias NamePlatinum-OncardiaPlatinum-EC-G
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionSingle-photon emission-computed tomography enhancersApoptosis stimulantsIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellPoint LLC
China Registration ClassN/A

Develop Information

Active CompaniesCellPoint LLC
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A